RecruitingNCT06655389

Correlation Between PLA Levels and Disease Severity in Patients With Sepsis Cardiac Insufficiency


Sponsor

Dongzhimen Hospital, Beijing

Enrollment

30 participants

Start Date

May 1, 2024

Study Type

OBSERVATIONAL

Conditions

Summary

Sepsis cardiac insufficiency is characterized by high morbidity and mortality. Studies have shown an association between elevated PLA levels in patients with sepsis and clinical outcomes of cardiac dysfunction. This study will explore the correlation between circulating PLA levels and organ dysfunction and disease severity in SIMD patients in the form of a cross-sectional study.


Eligibility

Min Age: 50 YearsMax Age: 90 Years

Plain Language Summary

Simplified for easier understanding

This study is investigating whether measuring PLA (platelet-leukocyte aggregates — clusters of blood cells that form during inflammation and infection) in the blood can help predict how severe heart problems are in ICU patients with sepsis. **You may be eligible if...** - You are between 50 and 90 years old - You are hospitalized in the ICU with a diagnosis of both sepsis and cardiac insufficiency (heart dysfunction caused by the infection) - You are within 24 hours of your diagnosis - Your condition meets specific severity scoring criteria **You may NOT be eligible if...** - You are outside the 50–90 age range - You do not have both sepsis and cardiac involvement - You were diagnosed more than 24 hours ago Talk to your doctor to see if this trial is right for you.

This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.

Interested in this trial?

Get notified about updates and connect with the research team.


Locations(1)

DongzhimenH,Beijing

Beijing, Beijing Municipality, China

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT06655389